FIELD: chemistry.
SUBSTANCE: invention relates to a polymer comprising hydroxypropyl methyl cellulose acetate succinate (HPMC-AS) wherein a percentage of a total degree of substitution (DS) of succinoyl in position C6-OH is less than or equal to 6% (C6 C3Suc, % ≤ 6%) and in position C3-OH is from 58 to 84% (58% < C3 C3Suc, % < 84%), and percentage of a total DS of acetyl in position C6-OH ranges from 33 to 51% (33% < C6 C3Ac, % < 51%) and in position C3-OH ranges from 16 to 20% (16% < C3 C3Ac, % < 20%). Invention relates to a composition for improving the efficiency and improving the processability of a medicament that comprises a medicament and a said polymer, as well as a process for the preparation of hydroxypropyl methyl cellulose acetate succinate (HPMC-AS) having a percentage of a total DS of succinoyl in position C6-OH less than or equal to 6% (C6 C3Suc, % ≤ 6%) and in position C3-OH from 58 to 84% (58% < C3 C3Suc, % < 84%), and a percentage of a total DS of acetyl, in position C6-OH of 33 to 51% (33% < C6 C3Ac, % < 51%) and in position C3-OH of 16 to 20% (16% < C3 C3Ac, % < 20%), comprising steps of (a) reacting acetic anhydride and sodium acetate with hydroxyl propyl methylcellulose to form an intermediate at a temperature in the range of from about 85 to about 115°C; (b) maintaining the temperature for a period of 30 minutes to 2.5 hours and (c) reacting succinic anhydride with the intermediate product at a temperature for a period of 2.5 to 23.5 hours to obtain HPMC-AS.
EFFECT: increasing the effectiveness of the drug and improving processability.
10 cl, 16 dwg, 11 tbl
Title | Year | Author | Number |
---|---|---|---|
THE PHARMACEUTICAL COMPOSITIONS CONTAINING pH - DEPENDENT MEDICAL PRODUCT, THE pH MODIFIER AND THE SLOWING DOWN AGENT | 2006 |
|
RU2442574C2 |
AMORPHOUS (5-FLUORO-2-METHYL-3-QUINOLIN-2-YLMETHYLINDOL-1-YL)-ACETIC ACID | 2012 |
|
RU2616000C2 |
GALENICAL PREPARATIONS OF ORGANIC COMPOUNDS | 2010 |
|
RU2535090C2 |
CONTROLLED RELEASE SOLID DRUG | 2006 |
|
RU2467740C2 |
CONTROLLED RELEASE SOLID PREPARATION | 2006 |
|
RU2496480C2 |
SLOW-RELEASE MATRIX PREPARATION CONTAINING BASE AGENT OR ITS SALT AND METHOD FOR MAKING THEREOF | 2005 |
|
RU2390354C2 |
POWDERS FOR PREPARING LIQUID DOSAGE FORM | 2008 |
|
RU2477133C2 |
FLUOXETINE ENTEROSOLUBLE GRANULES, COMPOSITION, GELATIN CAPSULE, METHOD OF TREATMENT OF HUMANS AND METHOD OF PREPARING FLUOXETHINE-CONTAINING ENTEROSOLUBLE CAPSULE | 1998 |
|
RU2164405C2 |
SOLID DISPERSIONS, CONTAINING KINASE INHIBITORS | 2011 |
|
RU2566716C2 |
PHARMACEUTICAL COMPOSITIONS | 2005 |
|
RU2373923C2 |
Authors
Dates
2018-06-06—Published
2014-02-21—Filed